There are 2789 resources available
397P - R-IMMUNE interim analysis: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer
Presenter: Javier Carrasco
Session: ePoster Display
398P - AI-powered whole-slide image analysis of tumor-infiltrating lymphocytes for prediction of prognosis in colorectal cancer
Presenter: Changhee Park
Session: ePoster Display
399P - Functional MRI in locally advanced rectal cancer: Can novel MRI techniques predict response to total neoadjuvant therapy?
Presenter: Gehan Khedr
Session: ePoster Display
400P - Baseline expression of RAD23B protein in circulating tumor cells correlates with complete pathological response of neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Presenter: Virgilio E Silva
Session: ePoster Display
401P - Translation of the IDEA trial into clinical practice: Evaluation of implementation of a new guideline
Presenter: Karlijn Rooijen van
Session: ePoster Display
402P - Chemoradiation versus less intensive treatments in stage I squamous cell carcinoma of the anal canal (SCCA)
Presenter: Rachel Riechelmann
Session: ePoster Display
404P - The clinical value of C-reactive protein and its association with tumour sidedness in patients undergoing curative surgery for colorectal cancer: A ScotScan collaborative study
Presenter: Anniken Joerlo Fuglestad
Session: ePoster Display
405P - Prognostic value of neoadjuvant rectal score in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
Presenter: Ana Carlota Caetano
Session: ePoster Display
406P - The analysis of driver mutations in paired samples of rectal carcinomas obtained before and after neoadjuvant chemoradiotherapy
Presenter: Evgeny Imyanitov
Session: ePoster Display
407P - Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer
Presenter: Andrea Pretta
Session: ePoster Display